Search results for: 'outsourcing ofstrive processing expand opportunities'

This research service provides an overview of the US revenue cycle management, revenue forecast, and competitive analysis of various legacy and modular RCM solutions. This study explores RCM applications across front-end, middle, and back-end processes and the end users are hospitals and ambulatory physician practices. In addition, it offers detail...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metabolic disease, rare disorders, neuropsychiatry, and ne...

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion models, and structure-based models are expanding the u...

23 Dec 2020  |  North America  |  Market Research

Growth Opportunity Analysis of the North American Clinical Documentation Improvement (CDI) Market

Internal Challenges, Disruptive Technologies, and Competitive Intensity are Driving CDI to become a More Value-based Process

Infographics

×

This Frost & Sullivan research service presents a comprehensive overview of the North American clinical documentation improvement (CDI) market. CDI is a mid-process in the broader revenue cycle management (RCM) ecosystem. This study analyzes key product segments, major end users, and top vendors across the United States and Canada. Revenue is fo...

HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and discussions with industry leaders, a consistent me...

This Industry Docket provides a brief overview of the healthcare opportunity landscape in Bahrain, its position among GCC countries, its health indicators and availability of healthcare facilities, changing scenarios of payer and providers, past and future trends in inpatients and outpatients. Infrastructure and care division across the private and...

As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clinical research.These disruptions continue to drive ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides strategic insights into frontier innovations redefining therapeutic development, precision diagnostics, and immune modulating interventions. It showcases breakthroughs across engineered phage therapeutics, intracellular peptide platforms, advanced gene ...